Výsledky vyhledávání - Deepak Sampath
- Zobrazuji výsledky 1 - 20 z 45
- Přejít na další stránku
-
1
-
2
-
3
-
4
Patterns for RANTES Secretion and Intercellular Adhesion Molecule 1 Expression Mediate Transepithelial T Cell Traffic Based on Analyses In Vitro and In Vivo Autor Masahiko Taguchi, Deepak Sampath, Takeharu Koga, Mario Castro, Dwight C. Look, Shin Nakajima, Michael J. Holtzman
Vydáno 1998Artigo -
5
-
6
-
7
Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax Autor Joel D. Leverson, Deepak Sampath, Andrew J. Souers, Saul H. Rosenberg, Wayne J. Fairbrother, Martine Amiot, Marina Konopleva, Anthony Letai
Vydáno 2017Revisão -
8
Ligand-Independent HER2/HER3/PI3K Complex Is Disrupted by Trastuzumab and Is Effectively Inhibited by the PI3K Inhibitor GDC-0941 Autor Teemu T. Junttila, Robert W. Akita, Kathryn L. Parsons, Carter T. Fields, Gail D. Lewis Phillips, Lori S. Friedman, Deepak Sampath, Mark X. Sliwkowski
Vydáno 2009Artigo -
9
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway Autor Guanglei Zhuang, Xiumin Wu, Zhaoshi Jiang, Ian Kasman, Jenny Yao, Yinghui Guan, Jason Oeh, Zora Modrušan, Carlos Bais, Deepak Sampath, Napoleone Ferrara
Vydáno 2012Artigo -
10
GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death <i>In Vitro</i> and <i>In Vivo</i> Autor Jeffrey J. Wallin, Jane Guan, Wei Wei Prior, Leslie B. Lee, Leanne Berry, Lisa D. Belmont, Hartmut Koeppen, Marcia Belvin, Lori S. Friedman, Deepak Sampath
Vydáno 2012Artigo -
11
-
12
The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma Autor Cyrille Touzeau, Christelle Dousset, Steven Le Gouill, Deepak Sampath, Joel D. Leverson, Andrew J. Souers, Sophie Maïga, Marie C. Béné, Philippe Moreau, Catherine Pellat‐Deceunynck, Martine Amiot
Vydáno 2013Carta -
13
Bcl-2/Bcl-xL Inhibition Increases the Efficacy of MEK Inhibition Alone and in Combination with PI3 Kinase Inhibition in Lung and Pancreatic Tumor Models Autor Nguyen Tan, Maureen Wong, Michelle Nannini, Rebecca Hong, Leslie B. Lee, S. Russ Price, Karen Williams, Pascal Savy, Peng Yue, Deepak Sampath, Jeffrey Settleman, Wayne J. Fairbrother, Lisa D. Belmont
Vydáno 2013Artigo -
14
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response Autor Ioannis K. Zervantonakis, Claudia Iavarone, Hsing‐Yu Chen, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge
Vydáno 2017Artigo -
15
Preclinical efficacy of MEK inhibition in Nras-mutant AML Autor Michael R. Burgess, Eugene Hwang, Ari Firestone, Tannie Q. Huang, Jin Xu, Johannes Zuber, Natacha Bohin, Tiffany Wen, Scott C. Kogan, Kevin M. Haigis, Deepak Sampath, Scott W. Lowe, Kevin Shannon, Qing Li
Vydáno 2014Artigo -
16
Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3′ Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models Autor Carol O’Brien, Jeffrey J. Wallin, Deepak Sampath, Debraj GuhaThakurta, Heidi Savage, Elizabeth A. Punnoose, Jane Guan, Leanne Berry, Wei Wei Prior, Lukas C. Amler, Marcia Belvin, Lori S. Friedman, Mark R. Lackner
Vydáno 2010Artigo -
17
Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness Autor Claudia Iavarone, Ioannis K. Zervantonakis, Laura M. Selfors, Sangeetha Palakurthi, Joyce F. Liu, Ronny Drapkin, Ursula A. Matulonis, Dorothy Hallberg, Victor E. Velculescu, Joel D. Leverson, Deepak Sampath, Gordon B. Mills, Joan S. Brugge
Vydáno 2019Artigo -
18
Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ acute myeloid leukemia models Autor Raghuveer Singh Mali, Qi Zhang, RosaAnna DeFilippis, Antonio Cavazos, Vinitha M. Kuruvilla, Jayant Raman, Vidhi Mody, Edna F. Choo, Monique Dail, Neil P. Shah, Marina Konopleva, Deepak Sampath, Elisabeth A. Lasater
Vydáno 2020Artigo -
19
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer Autor Uzma Asghar, Alexis R. Barr, Ros Cutts, Matthew Beaney, Irina S. Babina, Deepak Sampath, Jennifer M. Giltnane, Jennifer A. Lacap, Lisa Crocker, Amy Young, Alex Pearson, María Teresa Herrera-Abreu, Chris Bakal, Nicholas C. Turner
Vydáno 2017Artigo -
20
Dependence of Tumor Cell Lines and Patient-Derived Tumors on the NAD Salvage Pathway Renders Them Sensitive to NAMPT Inhibition with GNE-618 Autor Yang Xiao, Kristi Elkins, Jenni Durieux, Leslie Lee, Jason Oeh, Lulu Yang, Xiaorong Liang, Chris DelNagro, Jarrod R. Tremayne, Mandy Kwong, Bianca M. Liederer, Peter K. Jackson, Lisa D. Belmont, Deepak Sampath, Thomas O’Brien
Vydáno 2013Artigo
Vyhledávací nástroje:
Související témata
Biology
Cancer research
Cell biology
Medicine
Genetics
Cancer
Biochemistry
Internal medicine
Pharmacology
Gene
Immunology
Signal transduction
Chemistry
PI3K/AKT/mTOR pathway
In vivo
Leukemia
Chronic lymphocytic leukemia
Venetoclax
Apoptosis
Breast cancer
Oncology
Biotechnology
In vitro
Kinase
MAPK/ERK pathway
Protein kinase B
Bioinformatics
Cell culture
Downregulation and upregulation
Enzyme